Literature DB >> 30321741

Cancer cachexia and myopenia - Update on management strategies and the direction of future research for optimizing body composition in cancer - A narrative review.

Edward T Pring1, George Malietzis2, Robin H Kennedy2, Thanos Athanasiou3, John T Jenkins2.   

Abstract

PURPOSE: Body composition degenerates with cancer. Optimizing body composition is rarely, if ever, undertaken. This narrative review highlights and evaluates emerging treatments that have the potential to improve outcomes for our cancer patients. OBSERVATIONS: Body composition in cancer patients has been shown to be modifiable; enhanced body composition is associated with improved short term, long-term outcomes and survival in addition to improvements in function and quality of life. CONCLUSIONS AND RELEVANCE: A multimodal approach to body composition optimization formulated by a multidisciplinary team in a patient-centric manner can improve outcome. As part of a multifaceted approach to patient treatment, body composition modification should be considered to expand our armoury in fighting the systemic burden of cancer. Crown
Copyright © 2018. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Cachexia; Muscle modification; Myopenia; Sarcopenia

Mesh:

Year:  2018        PMID: 30321741     DOI: 10.1016/j.ctrv.2018.10.002

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  4 in total

1.  Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival.

Authors:  Xiao Huang; Jie Ma; Ling Li; Xiao-Dong Zhu
Journal:  Cancer Med       Date:  2019-09-13       Impact factor: 4.452

2.  Skeletal muscle wasting and long-term prognosis in patients undergoing rectal cancer surgery without neoadjuvant therapy.

Authors:  Alessandro Giani; Simone Famularo; Alessandro Fogliati; Luca Riva; Nicolò Tamini; Davide Ippolito; Luca Nespoli; Marco Braga; Luca Gianotti
Journal:  World J Surg Oncol       Date:  2022-02-25       Impact factor: 2.754

3.  Determining Malnutrition Assessment Criteria to Predict One-Year Mortality for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Authors:  Hang Huong Ling; Kun-Yun Yeh; Shu-Hang Ng; Cheng-Hsu Wang; Chien-Hong Lai; Tsung-Han Wu; Pei-Hung Chang; Wen-Chi Chou; Fang-Ping Chen; Yu-Ching Lin
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

4.  Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial.

Authors:  S J Moug; S J E Barry; S Maguire; N Johns; D Dolan; R J C Steele; C Buchan; G Mackay; A S Anderson; N Mutrie
Journal:  Tech Coloproctol       Date:  2020-06-20       Impact factor: 3.781

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.